Evaluation of sorption capacity of antibiotics and antibacterial properties of a cyclodextrin-polymer functionalized hydroxyapatite-coated titanium hip prosthesis

International Journal of Pharmaceutics

Volumn 477, Issue 1-2, 2014, Pages 380-389

  Taha, Mariam ^a,b   Chai, Feng ^a,b   Blanchemain, Nicolas ^a,b   Neut, Christel ^a,c   Goube, Michel ^d   Maton, Mickael ^a,b   Martel, Bernard ^a,e   Hildebrand, Hartmut F ^a,b  

^a UNIV LILLE   (France)

^b CHU de Lille   (France)

^c UNIVERSITÉ DE LILLE   (France)

^d BJR France RandD Department ^*  (France)

^e UNIVERSITÉ LILLE 1   (France)

Author keywords

Antibiotics; Cyclodextrin; Drug delivery system; Hip prosthesis; Infection

Indexed keywords

CYCLODEXTRIN; HYDROXYAPATITE; POLYMER; RIFAMPICIN; TITANIUM; TOBRAMYCIN;

ADSORPTION; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ENTEROBACTER CLOACAE; HIP PROSTHESIS; MATERIAL COATING; NONHUMAN; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; SUSTAINED DRUG RELEASE;

EID: 84911372645     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.10.026     Document Type: Article

References (43)

1. V. Alt, A. Bitschnau, F. Böhner, K.E. Heerich, E. Magesin, A. Sewing, T. Pavlidis, G. Szalay, C. Heiss, U. Thormann, S. Hartmann, W. Pabst, S. Wenisch, and R. Schnettler Effects of gentamicin and gentamicin-RGD coatings on bone in growth and biocompatibility of cementless joint prostheses: an experimental study in rabbits Acta Biomater. 7 2011 1274 1280
2. B. Baroli From natural bone graft to tissue engineering therapeutics: brainstorming on pharmaceutical formulative requirements and challenges J. Pharm. Sci. 98 2009 1317 1375
3. W.K. Barsoum, A. Klika, V.E. Krebs, and R. Molloy Retrospective analysis of infection rate after early reoperation in total hip arthroplasty Clin. Orthop. Relat. Res. 468 2010 2392 2423
4. N. Blanchemain, Y. Karrout, N. Tabary, C. Neut, M. Bria, J. Siepmann, H.F. Hildebrand, and B. Martel Methyl-β-cyclodextrin modified vascular prosthesis:Influence of the modification level on the drug delivery properties in different media Acta Biomater. 7 2011 304 314
5. N. Blanchemain, Y. Karrout, N. Tabary, M. Bria, C. Neut, H.F. Hildebrand, J. Siepmann, and B. Martel Comparative study of vascular prostheses coated with polycyclodextrins for controlled ciprofloxacin release Carbohydr. Polym. 90 2012 1695 1703
6. J.W. Bloom, and S.E. Wheeler Taking the aromaticity out of aromatic interactions Angew. Chem. Int. Ed. 50 2011 7847 7859
7. R.B. Bourne Antibiotic bone cement approval: fuss-in at the Feds! Orthopedics 25 2002 913 914
8. H.W. Buchholz, and H. Engelbrecht Über die depot wirkung einiger anti-biotika bei vennischung mit dem kunstharz Palacos Chirurg 41 1970 511 515
9. A.A. Campbell, L. Song, X.S. Li, B.J. Nelson, C. Bottoni, D.E. Brooks, and E.S. DeJong Development, characterization and anti-microbial efficacy of hydroxyapatite-chlorhexidine coatings produced by surface-induced mineralization J. Biomed. Mater. Res. 53 2000 400 407
10. D. Campoccia, L. Montanaro, and C.R. Arciola The significance of infection related to orthopedic devices and issues of antibiotic resistance Biomaterials 27 2006 2331 2339
11. J.H. Cho, J.P. Garino, S.K. Choo, K.Y. Han, and J.H. Kim Seven-year results of a tapered, titanium, hydroxyapatite-coated cementless femoral stem in primary total hip arthroplasty Clin. Orthop. Surg. 2 2010 214 220
12. H. Dale, G. Hallan, G. Hallan, B. Espehaug, L.I. Havelin, and L.B. Engesaeter Increasing risk of revision due to deep infection after hip arthroplasty Acta Orthop. 80 2009 639 645
13. Delaunay, C., Aghayev, E., Staub, L., 2009. Registre des Prothèses Totales de Hanche de la SOFCOT Rapport.
14. C. Delaunay, M. Hamadouche, J. Girard, A. Duhamel, and The SoFCOT Group What are the causes for failures of primary hip arthroplasties in France? Clinical Orthop. Relat. Res. 471 2013 3863 3869
15. R.M. Donlan, and J.W. Costerton Biofilms: survival mechanisms of clinically relevant microorganisms Clin. Microbiol. Rev. 15 2002 167 193
16. W.M. Dunne Jr. Bacterial adhesion: seen any good biofilms lately? Clin. Microbiol. Rev. 15 2002 155 166
17. L.B. Engesaeter, S.A. Lie, B. Espehaug, O. Furnes, S.E. Vollset, and L.I. Havelin Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemicallyand in bone cement on the revision rate of 22,170 primary hip replacements followed 1-14 years in the Norwegian Arthroplasty Register Acta Orthop. Scan 74 2003 644 651
18. C. Eunae, C. Jae Min, and J. Seunho Analysis on the molecular interactions between tobramycin: an aminoglycoside antibiotic and periplasmic glucans isolated from pseudomonas syringae Bull. Kor. Chem. Soc. 32 2011 347 349
19. L.P. Garrod Combined chemotherapy in bacterial infections Br. Med. J. 1 1953 953 957
20. O. Goëau-Brissonnière, C. Leport, F. Bacourt, C. Lebrault, R. Comte, and J.C. Pechère Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft Ann. Vasc. Surg. 5 1991 408 412
21. E.M. Hetrick, and M.H. Schoenfisch Reducing implant-related infections: active release strategies Chem. Soc. Rev. 35 2006 780 789
22. Market research, Hip replacement implants - global pipeline analysis competitivel and scape and market forecasts to 2017.
23. T.H. Hoang Thi, F. Chai, S. Leprêtre, N. Blanchemain, B. Martel, F. Siepmann, H.F. Hildebrand, J. Siepmann, and M.P. Flament Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gel Int. J. Pharm. 400 2010 74 85
24. I. Javerliat, O. Goëau-Brissonnière, V. Sivadon-Tardy, M. Coggia, and J.L. Gaillard Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics J. Vasc. Surg. 46 2007 1026 1031
25. I. Kacem, T. Laurent, N. Blanchemain, C. Neut, F. Chai, S. Haulon, H.F. Hildebrand, and B. Martel Dyeing and antibacterial activation with methylene blue of a cyclodextrin modified polyester vascular graft J. Biomed. Mat. Res. 102 2013 2942 2951
26. T. Kalicke, J. Schierholz, U. Schlegel, T.M. Frangen, M. Koller, G. Printzen, and D. Seybold Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study J. Orthop. Res. 24 2006 1622 1640
27. W.H. Kim, S.B. Lee, K.T. Oh, S.K. Moon, K.M. Kim, and K.N. Kim The release behavior of CHX from polymer-coated titanium surfaces Surf. Interface Anal. 40 2008 202 204
28. R.R. Maddikeri, S. Tosatti, M. Schuler, S. Chessari, M. Textor, R.G. Richards, and L.G. Harris Reduced medical infection related bacterial strains adhesion on bioactive RGD modified titanium surfaces: a first step toward cell selective surfaces J. Biomed. Mater. Res. A 84 2008 425 435
29. D. Neut, R.J. Dijkstra, J.I. Thompson, H.C. Van der Mei, and H.J. Busscher Antibacterial efficacy of a new gentamicin-coating for cementless prostheses compared to gentamicin-loaded bone cement J. Orthop. Res. 29 2011 1654 1661
30. O.C. El Helou, E.F. Berbari, C.E. Marculescu, W.I. El Atrouni, R.R. Razonable, J.M. Steckelberg, A.D. Hanssen, and D.R. Osmon Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? Clin. Infect. Dis. 47 2008 903 909
31. O'neill, L., O'sullivan, C., 2010. Method for coating metal implants with therapeutic mixtures. Patent number: WO 2010/113033.
32. C.J. Oosterbos, A.I. Rahmy, A.J. Tonino, and W. Witpeerd High survival rate of hydroxyapatite-coated hip prostheses: 100 consecutive hips followed for 10 years Acta Orthop. Scand. 75 2004 127 133
33. J.L. Pozo, and R. Patel Clinical practice. Infection associated with prosthetic joints N. Engl. J. Med. 361 2009 787 794
34. Z. Ruszczak, and W. Friess Collagen as a carrier for on-site delivery of antibacterial drugs Adv. Drug Deliv. Rev. 55 2003 1679 1698
35. G. Schmidmaier, M. Lucke, B. Wildemann, N.P. Haas, and M. Raschke Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review Injury 37 2006 S105 S112
36. M. Stigter, J. Bezemer, K. De Groot, and P. Layrolle Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy J. Control. Release 99 2004 127 137
37. M. Stigter, K. De Groot, and P. Layrolle Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium Biomaterials 23 2002 4143 4153
38. M. Taha, F. Chai, N. Blanchemain, M. Goube, B. Martel, and H.F. Hildebrand Validating the poly-cyclodextrins based local drug delivery system on plasma-sprayed hydroxyapatite coated orthopedic implant with toluidine blue O Mater. Sci. Eng. C Mater. Biol. Appl. 33 2013 2639 2647
39. F. Tewes, J. Brillault, W. Couet, and J.C. Olivier Formulation of rifampicin-cyclodextrin complexes for lung nebulization J. Control. Release 129 2008 93 99
40. B. Thomes, P. Murray, and D. Bouchier-Hayes Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo J. Bone Joint Surg. Br. 84B 2002 758 760
41. H. Van de Belt, D. Neut, J.R. van Horn, H.C. van der Mei, W. Schenk, and H.J. Busscher Antibiotic resistance - to treat or not to treat? Nat. Med. 5 1999 358 369
42. P. Wu, and D.W. Grainger Drug/device combinations for local drug therapies and infection prophylaxis Biomaterials 27 2006 2450 2467
43. M. Zilberman, and J.J. Elsner Antibiotic-eluting medical devices for various applications J. Control. Release 130 2008 202 215